Medindia LOGIN REGISTER
Medindia

Alzheimer’s Disease may be Caused by Liver Protein

by Karishma Abhishek on Sep 16 2021 7:00 AM

Alzheimer’s disease is found to be contributed by a peripherally produced protein in the liver – amyloid that also causes neurodegeneration in the brain.

Alzheimer’s Disease may be Caused by Liver Protein
Alzheimer’s disease is found to be contributed by a peripherally produced protein in the liver – amyloid that causes neurodegeneration in the brain as per a study at the Curtin University, published in the journal PLOS Biology.
Alzheimer's disease (AD) is a neurodegenerative disease that leads to gradual memory loss and behavioural changes. It is characterized by the formation of beta-amyloid plaques in the brain tissues, years before the actual symptoms occur.

It is known that A-beta is also present in other peripheral organs, and these increased levels of the protein in the blood raise the possibility of AD. But it has been difficult to trace out this hypothesis as the protein is also produced by the brain and distinguishing this protein from the two sources is challenging.

The present study thereby investigated the role of these proteins in the mouse model that produces human a-beta only in liver cells.

Liver Protein and Alzheimer's Disease

It was found that these mice had developed neurodegeneration and brain atrophy, accompanied by neurovascular inflammation and dysfunction of cerebral capillaries, as observed in AD.

Moreover, these mice also performed poorly on a learning test that was conclusive of hippocampus function – the brain structure essential for the formation of new memories.

Advertisement
The study thereby portrays that peripherally derived A-beta can cause neurodegeneration, especially those in the liver that serves as a potential contributor to human disease.

“While further studies are now needed, this finding shows the abundance of these toxic protein deposits in the blood could potentially be addressed through a person’s diet and some drugs that could specifically target lipoprotein amyloid, therefore reducing their risk or slowing the progression of Alzheimer’s disease,” says John Mamo, who led the study at the Curtin University in Bentley, Australia.

Advertisement
Source-Medindia


Advertisement